Review Note

Last Update: 04/01/2024 06:38 AM

Current Deck: Spring 2024 P1 Semester::Spring 2024 IE #5::Pharm 221 Biostats

Published

Currently Published Content

Text

case series strengths

study results are closer to those of {{c1::routine clinical practice}}
may be useful when a {{c1::RCT is challenging to do}}
high {{c2::external validity}}
{{c2::cost effective and time saving}}

case series weakness

cannot make {{c3::cause and effect claims}}
susceptible to {{c3::selection and measurement bias}}
{{c4::absolute risk}} cannot be calculated
data collection may be {{c4::incomplete}}

Back Extra

No published tags.

Pending Suggestions

No pending suggestions for this note.